Yusuf, Salim

Atrial Fibrillation and Risk of Clinical Events in Chronic Heart Failure With and Without Left Ventricular Systolic Dysfunction

Olsson, L. G., Swedberg, K., Ducharme, A., Granger, C. B., Michelson, E. L., McMurray, J. J. V., Puu, M., Yusuf, S., & Pfeffer, M. A. (2006) · Journal of the American College of Cardiology

Atrial Fibrillation Management and OutcomesHeart Failure Treatment and Management

Cited by 574

Urinary sodium and potassium excretion and risk of cardiovascular events

O'Donnell, M. J., Yusuf, S., Mente, A., Gao, P., Mann, J. F., Teo, K., McQueen, M., Sleight, P., Sharma, A. M., Dans, A., et al. (2011) · JAMA

Sodium Intake and HealthBlood Pressure and Hypertension Studies

Cited by 564

Ramipril and the Development of Diabetes

Yusuf, S. (2001) · JAMA

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 541

Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry

Shindler, D. M., Kostis, J. B., Yusuf, S., Quinones, M. A., Pitt, B., Stewart, D., Pinkett, T., Ghali, J. K., Wilson, A. C., & The SOLVD Investigators (1996) · The American Journal of Cardiology

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 516

Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials

Dagenais, G. R., Pogue, J., Fox, K., Simoons, M. L., & Yusuf, S. (2006) · The Lancet

Renin-Angiotensin System StudiesBlood Pressure and Hypertension Studies

Cited by 514

Food Consumption and its Impact on Cardiovascular Disease: Importance of Solutions Focused on the Globalized Food System

Anand, S. S., Hawkes, C., de Souza, R. J., Mente, A., Dehghan, M., Nugent, R., Zulyniak, M. A., Weis, T., Bernstein, A. M., Krauss, R. M., et al. (2015) · Journal of the American College of Cardiology

Nutritional Studies and DietCardiovascular Health and Risk Factors

Cited by 507

The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study

Hijazi, Z., Oldgren, J., Lindbäck, J., Alexander, J. H., Connolly, S. J., Eikelboom, J. W., Ezekowitz, M. D., Held, C., Hylek, E. M., Lopes, R. D., et al. (2016) · The Lancet

Atrial Fibrillation Management and OutcomesInflammatory Biomarkers in Disease Prognosis

Cited by 490

Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial

Dans, A. L., Connolly, S. J., Wallentin, L., Yang, S., Nakamya, J., Brueckmann, M., Ezekowitz, M., Oldgren, J., Eikelboom, J. W., Reilly, P. A., et al. (2013) · Circulation

Atrial Fibrillation Management and OutcomesAntiplatelet Therapy and Cardiovascular Diseases

Cited by 484

Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies

Mente, A., O'Donnell, M., Rangarajan, S., Dagenais, G., Lear, S., McQueen, M., Diaz, R., Avezum, A., Lopez-Jaramillo, P., Lanas, F., et al. (2016) · The Lancet

Sodium Intake and HealthBlood Pressure and Hypertension Studies

Cited by 483

Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease

Anand, S. S., Caron, F., Eikelboom, J. W., Bosch, J., Dyal, L., Aboyans, V., Abola, M. T., Branch, K. R. H., Keltai, K., Bhatt, D. L., et al. (2018) · Journal of the American College of Cardiology

Peripheral Artery Disease ManagementAntiplatelet Therapy and Cardiovascular Diseases

Cited by 466

Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial

Diener, H.-C., Connolly, S. J., Ezekowitz, M. D., Wallentin, L., Reilly, P. A., Yang, S., Xavier, D., Di Pasquale, G., & Yusuf, S. (2010) · The Lancet Neurology

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 451

Dietary Patterns and the Risk of Acute Myocardial Infarction in 52 Countries: Results of the INTERHEART Study

Iqbal, R., Anand, S., Ounpuu, S., Islam, S., Zhang, X., Rangarajan, S., Chifamba, J., Al-Hinai, A., Keltai, M., & Yusuf, S. (2008) · Circulation

Nutritional Studies and DietCardiovascular Health and Risk Factors

Cited by 447

Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia

Johansen, C. T., Wang, J., Lanktree, M. B., Cao, H., McIntyre, A. D., Ban, M. R., Martins, R. A., Kennedy, B. A., Hassell, R. G., Visser, M. E., et al. (2010) · Nature Genetics

Lipid metabolism and disordersGenetic Associations and Epidemiology

Cited by 437

Need for expertise based randomised controlled trials

Devereaux, P. J., Bhandari, M., Clarke, M., Montori, V. M., Cook, D. J., Yusuf, S., Sackett, D. L., Cinà, C. S., Walter, S. D., Haynes, B., et al. (2005) · BMJ

Statistical Methods in Clinical TrialsHealth Policy Implementation Science

Cited by 427

Cumulating evidence from randomized trials: Utilizing sequential monitoring boundaries for cumulative meta-analysis

Pogue, J. M., & Yusuf, S. (1997) · Controlled Clinical Trials

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 415

Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation: A Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Substudy

Hijazi, Z., Oldgren, J., Andersson, U., Connolly, S. J., Ezekowitz, M. D., Hohnloser, S. H., Reilly, P. A., Vinereanu, D., Siegbahn, A., Yusuf, S., et al. (2012) · Circulation

Atrial Fibrillation Management and OutcomesHeart Failure Treatment and Management

Cited by 402

Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation: A RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) Trial Analysis

Hijazi, Z., Hohnloser, S. H., Oldgren, J., Andersson, U., Connolly, S. J., Eikelboom, J. W., Ezekowitz, M. D., Reilly, P. A., Siegbahn, A., Yusuf, S., et al. (2014) · Circulation

Atrial Fibrillation Management and OutcomesVenous Thromboembolism Diagnosis and Management

Cited by 396

Association of estimated sleep duration and naps with mortality and cardiovascular events: a study of 116 632 people from 21 countries

Wang, C., Bangdiwala, S. I., Rangarajan, S., Lear, S. A., AlHabib, K. F., Mohan, V., Teo, K., Poirier, P., TSE, L. A., Liu, Z., et al. (2019) · European Heart Journal

Sleep and related disordersSleep and Work-Related Fatigue

Cited by 385

PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study

Schmidt, A. F., Swerdlow, D. I., Holmes, M. V., Patel, R. S., Fairhurst-Hunter, Z., Lyall, D. M., Hartwig, F. P., Horta, B. L., Hyppönen, E., Power, C., et al. (2017) · The Lancet Diabetes & Endocrinology

Lipoproteins and Cardiovascular HealthGenetic Associations and Epidemiology

Cited by 380

Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study

Diener, H.-C., Sacco, R. L., Yusuf, S., Cotton, D., Ôunpuu, S., Lawton, W. A., Palesch, Y., Martin, R. H., Albers, G. W., Bath, P., et al. (2008) · The Lancet Neurology

Acute Ischemic Stroke ManagementAntiplatelet Therapy and Cardiovascular Diseases

Cited by 359

Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program

Ducharme, A., Swedberg, K., Pfeffer, M. A., Cohen-Solal, A., Granger, C. B., Maggioni, A. P., Michelson, E. L., McMurray, J. J. V., Olsson, L., Rouleau, J. L., et al. (2006) · American Heart Journal

Atrial Fibrillation Management and OutcomesHeart Failure Treatment and Management

Cited by 352

Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study

Mente, A., O'Donnell, M., Rangarajan, S., McQueen, M., Dagenais, G., Wielgosz, A., Lear, S., Ah, S. T. L., Wei, L., Diaz, R., et al. (2018) · The Lancet

Sodium Intake and HealthBlood Pressure and Hypertension Studies

Cited by 332

Pathology of Peripheral Artery Disease in Patients With Critical Limb Ischemia

Narula, N., Dannenberg, A. J., Olin, J. W., Bhatt, D. L., Johnson, K. W., Nadkarni, G., Min, J., Torii, S., Poojary, P., Anand, S. S., et al. (2018) · Journal of the American College of Cardiology

Peripheral Artery Disease ManagementAortic Thrombus and Embolism

Cited by 326

Effects of exercise training in patients with heart failure: The Exercise Rehabilitation Trial (EXERT)

McKelvie, R. S., Teo, K. K., Roberts, R., McCartney, N., Humen, D., Montague, T., Hendrican, K., & Yusuf, S. (2002) · American Heart Journal

Cardiovascular and exercise physiologyCardiac Health and Mental Health

Cited by 322